Reuters logo
4 years ago
BRIEF-Cubist Pharma up 9.5 percent premarket after antibiotic succeeds in late-stage trial
December 16, 2013 / 1:50 PM / 4 years ago

BRIEF-Cubist Pharma up 9.5 percent premarket after antibiotic succeeds in late-stage trial

NEW YORK, Dec 16 (Reuters) - Cubist Pharmaceuticals Inc : * Pharma up 9.5 percent to $68.75 in premarket after antibiotic succeeds in late-stage trial

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below